Data and Insights
The 99.6% Retention Reality: How "Ease of Use" Plugs the Launch Leak
Patient Churn has dropped to virtually zero. The data proves that when a platform fits the workflow, patients and doctors, stay.
The 'Secondary' Specialist is Now Your Primary Driver: Why Cardiologists Are Outperforming Diabetologists in PSP Engagement
New data shows that "non-primary" specialists aren't just participating, they are engaging with higher velocity than the core therapeutic owners.
The Trust Curve: Why HCPs Are Moving from "Rescuing" Patients to "Starting" Them
The ratio of "New-to-Therapy" patients has jumped by 14%. This is the clearest data signal that HCP trust is maturing.
Beyond the App: Building a "One Touch, Always On" Digital Infrastructure for Universal Vaccination Access
Privacy, simplicity, and universal access must be the pillars of any national vaccination reminder system. Introducing Vaccination Reminder.
The "Invisible Barrier" in Immunization: Why Supply Is No Longer the Only Challenge to European Public Health
Vaccine hesitancy is a loud problem, but "Vaccine Forgetfulness" is a silent epidemic. Tailored, authority-endorsed digital reminders are the missing infrastructure in our National Vaccination Strategies.
The 2.9% 'Launch Leak': Why Patient Churn Begins Immediately (And How to See It)
Our data shows nearly 3% of patients dropped off in the initial launch phase. If you wait for prescription refill data, you’re already too late.
The 61% Insight: Our Launch Data Reveals Most PSP Patients Are Enrolled Mid-Treatment, Not at Day 1
If your Patient Support Program is built only for "new-to-therapy" patients, you're overlooking the majority. Are you supporting the right patient journey?
Data Shows 63% of Registered HCPs Don't Enroll a Single Patient. Here’s How to Bridge the 'Activation Gap.
Launch data reveals a critical gap between HCP intent and action. How can pharma teams and physicians close it?
Beyond the Primary Prescriber: Analyzing PSP Adoption Trends Across Specialist Cohorts
Launch data reveals a 137% gap in patient enrollment velocity between key specialists. How can pharma teams and HCPs bridge this disconnect?